NeoPharm CO., LTD. (KOSDAQ: 092730)
South Korea
· Delayed Price · Currency is KRW
11,860
-120 (-1.00%)
Dec 20, 2024, 9:00 AM KST
NeoPharm CO., LTD. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 112,200 | 97,105 | 85,033 | 87,931 | 81,625 | 83,240 | Upgrade
|
Other Revenue | - | - | -0 | - | - | - | Upgrade
|
Revenue | 112,200 | 97,105 | 85,033 | 87,931 | 81,625 | 83,240 | Upgrade
|
Revenue Growth (YoY) | 21.60% | 14.20% | -3.30% | 7.72% | -1.94% | 25.60% | Upgrade
|
Cost of Revenue | 44,306 | 31,720 | 26,653 | 25,544 | 22,984 | 23,136 | Upgrade
|
Gross Profit | 67,894 | 65,385 | 58,380 | 62,386 | 58,642 | 60,104 | Upgrade
|
Selling, General & Admin | 38,369 | 36,276 | 32,984 | 36,022 | 32,991 | 33,958 | Upgrade
|
Research & Development | 3,035 | 2,647 | 2,854 | 2,935 | 2,802 | 2,518 | Upgrade
|
Operating Expenses | 42,979 | 40,078 | 36,941 | 39,955 | 36,740 | 37,144 | Upgrade
|
Operating Income | 24,915 | 25,307 | 21,439 | 22,431 | 21,902 | 22,961 | Upgrade
|
Interest Expense | -42.54 | -21.32 | -8.84 | -38.46 | -56.37 | -17.17 | Upgrade
|
Interest & Investment Income | 4,194 | 4,588 | 2,077 | 1,177 | 1,366 | 1,252 | Upgrade
|
Currency Exchange Gain (Loss) | -151.13 | -117.74 | 205.38 | 662.9 | -126.04 | 24.92 | Upgrade
|
Other Non Operating Income (Expenses) | -563.91 | -362.95 | -376.73 | -430.38 | -138.91 | -424.3 | Upgrade
|
EBT Excluding Unusual Items | 28,351 | 29,393 | 23,335 | 23,801 | 22,947 | 23,796 | Upgrade
|
Gain (Loss) on Sale of Investments | -61.22 | -2.76 | - | 48.48 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -14.46 | -3.7 | -6.05 | -3.23 | -10.81 | -7.28 | Upgrade
|
Asset Writedown | -1.58 | -13.47 | -6.23 | -11.07 | - | -250.66 | Upgrade
|
Other Unusual Items | - | - | - | - | - | 2.93 | Upgrade
|
Pretax Income | 28,274 | 29,373 | 23,323 | 23,836 | 22,936 | 23,541 | Upgrade
|
Income Tax Expense | 5,940 | 6,160 | 6,296 | 6,122 | 4,805 | 4,296 | Upgrade
|
Net Income | 22,334 | 23,213 | 17,027 | 17,713 | 18,131 | 19,245 | Upgrade
|
Net Income to Common | 22,334 | 23,213 | 17,027 | 17,713 | 18,131 | 19,245 | Upgrade
|
Net Income Growth | 7.72% | 36.33% | -3.87% | -2.30% | -5.79% | 25.22% | Upgrade
|
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 15 | Upgrade
|
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 | 15 | Upgrade
|
Shares Change (YoY) | - | - | - | -0.95% | 4.38% | 5.80% | Upgrade
|
EPS (Basic) | 1427.89 | 1484.07 | 1088.60 | 1132.47 | 1159.17 | 1284.83 | Upgrade
|
EPS (Diluted) | 1427.89 | 1484.00 | 1088.50 | 1132.47 | 1148.00 | 1272.00 | Upgrade
|
EPS Growth | 7.77% | 36.33% | -3.88% | -1.35% | -9.75% | 18.33% | Upgrade
|
Free Cash Flow | -5,826 | 3,411 | 17,707 | 21,361 | 16,788 | 13,322 | Upgrade
|
Free Cash Flow Per Share | -372.46 | 218.06 | 1132.04 | 1365.69 | 1063.18 | 880.60 | Upgrade
|
Dividend Per Share | 375.000 | 375.000 | 350.000 | 350.000 | 325.000 | 375.000 | Upgrade
|
Dividend Growth | 7.14% | 7.14% | 0% | 7.69% | -13.33% | 15.38% | Upgrade
|
Gross Margin | 60.51% | 67.33% | 68.66% | 70.95% | 71.84% | 72.21% | Upgrade
|
Operating Margin | 22.21% | 26.06% | 25.21% | 25.51% | 26.83% | 27.58% | Upgrade
|
Profit Margin | 19.91% | 23.90% | 20.02% | 20.14% | 22.21% | 23.12% | Upgrade
|
Free Cash Flow Margin | -5.19% | 3.51% | 20.82% | 24.29% | 20.57% | 16.00% | Upgrade
|
EBITDA | 27,688 | 26,980 | 23,055 | 23,931 | 23,396 | 24,169 | Upgrade
|
EBITDA Margin | 24.68% | 27.78% | 27.11% | 27.22% | 28.66% | 29.04% | Upgrade
|
D&A For EBITDA | 2,773 | 1,673 | 1,616 | 1,500 | 1,494 | 1,209 | Upgrade
|
EBIT | 24,915 | 25,307 | 21,439 | 22,431 | 21,902 | 22,961 | Upgrade
|
EBIT Margin | 22.21% | 26.06% | 25.21% | 25.51% | 26.83% | 27.58% | Upgrade
|
Effective Tax Rate | 21.01% | 20.97% | 27.00% | 25.69% | 20.95% | 18.25% | Upgrade
|
Advertising Expenses | - | 12,408 | 11,533 | 14,695 | 12,686 | 11,410 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.